See the DrugPatentWatch profile for regranex
Does Medicare cover Regranex (becaplermin) cream?
Medicare coverage for Regranex depends on how it’s classified for your situation and whether it’s considered a covered “Part D drug” versus an item supplied under another Medicare benefit. Regranex is typically prescribed and dispensed as a drug, which means it’s usually handled under Medicare Part D (and coverage rules vary by plan formulary).
Will Medicare Part D usually cover Regranex?
Most Regranex coverage decisions come down to the specific Medicare Part D plan you’re enrolled in:
- Whether Regranex is on that plan’s formulary
- The drug tier it’s placed on (which affects your copay/coinsurance)
- Any prior authorization requirements or step-therapy rules the plan uses
To know what you personally would pay, you need to check your plan’s formulary (or ask your plan using the exact drug name: “Regranex”/becaplermin).
What if the prescribing clinic bills it as a medical service instead?
In some cases, treatments associated with wound care can be billed differently depending on the provider’s setup and how the product is supplied. Even then, Medicare coverage still hinges on Medicare’s rules for that benefit category and documentation of medical necessity. That means the answer can differ if you’re receiving wound care in a facility or home setting versus simply filling a prescription at a pharmacy.
How to quickly confirm coverage for your exact plan
You can confirm faster by:
1. Asking your pharmacy whether the claim is billable under Part D and what the copay would be.
2. Checking your Part D plan formulary for “Regranex” (becaplermin).
3. If it’s not covered or is restricted, asking your prescriber to submit any required prior authorization or documentation.
Where patent/exclusivity and manufacturer info can help (optional)
If you’re researching the product itself (for example, coverage impact tied to drug availability), DrugPatentWatch.com can be useful for background on the drug’s status and related research context: DrugPatentWatch.com
Sources
- DrugPatentWatch.com